Gender differences in the regulation of 3α-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress protection

Neuroscience

Volumn 120, Issue 2, 2003, Pages 541-549

  Mitev, Y A ^a   Darwish, M ^b   Wolf, S S ^a   Holsboer, F ^b   Almeida, O F X ^b   Patchev, V K ^a  

^a BAYER PHARMA AG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Development; Neonatal stress; Neurosteroid biosynthesis; Sex differentiation; Steroid hormones

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; NEUROSTEROID; TETRAHYDROPROGESTERONE; 2,3,10,11 TETRAHYDROXYTETRAHYDROPROTOBERBERINE; 2,3,10,11-TETRAHYDROXYTETRAHYDROPROTOBERBERINE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; BERBERINE DERIVATIVE; CORTICOSTERONE; DEOXYCORTICOSTERONE; DRUG DERIVATIVE; TETRAHYDRODEOXYCORTICOSTERONE;

ADRENALECTOMY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GONAD; GONADECTOMY; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE SUBSTITUTION; MALE; MATERNAL DEPRIVATION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; RAT; REGULATORY MECHANISM; RNA ANALYSIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STEROID RELEASE; STEROIDOGENESIS; STRESS; ANIMAL; ANXIETY DISORDER; BLOOD; CASTRATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; IN SITU HYBRIDIZATION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PREGNANCY; SEXUAL DEVELOPMENT; TIME; WISTAR RAT;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ANXIETY DISORDERS; BERBERINE ALKALOIDS; BRAIN; CASTRATION; CORTICOSTERONE; DESOXYCORTICOSTERONE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IN SITU HYBRIDIZATION; MALE; PREGNANCY; RATS; RATS, WISTAR; RNA, MESSENGER; SEX CHARACTERISTICS; TIME FACTORS;

EID: 0141957928     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00287-2     Document Type: Article

References (38)

1. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology. 125:1996;65-73.
2. Cheng K.C., Lee J., Khanna M., Qin K.-N. Distribution and ontogeny of 3α-hydroxysteroid dehydrogenase in the rat brain. J Steroid Biochem Mol Biol. 50:1994;85-89.
3. Condé GL, Canteros MG, Deicke J, Merriam GR, Patchev VK, Holsboer F, Almeida OFX (1998) Neurosteroid antagonism of adrenalectomy-induced apoptosis in the rat dentate gyrus. Twenty-fourth annual meeting of the Society for Neuroscience, abstract 418.17.
4. Dawson G.R., Tricklebank M.D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci. 16:1995;33-36.
5. Diaz-Veliz G., Alarcon T., Espinoza C., Dussaubat N., Mora S. Ketanserin and anxiety levels influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats . Pharmacol Biochem Behav. 58:1997;637-642.
6. Eechaute W.P., Dhooge W.S., Gao C.Q., Calders P., Rubens R., Weyne J., Kaufman J.K. Progesterone-transforming enzyme activity in the hypothalamus of the male rat. J Steroid Biochem Mol Biol. 70:1999;159-167.
7. Gao C.Q., Dhooge W.S., Kaufman J.M., Weyne J.J., Eechaute W.P. Hypothalamic 5α-reductase and 3α-oxidoreductase activity in the male rat. J Steroid Biochem Mol Biol. 80:2002;91-98.
8. - flux across development in rat cerebral cortex. Dev Brain Res. 131:2001;31-39.
9. Hou Y.T., Lin H.K., Penning T.M. Dexamethasone regulation of the rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase gene. Mol Pharmacol. 53:1998;459-466.
10. Johnston A.L., File S.E. Sex differences in animal tests of anxiety. Physiol Behav. 49:1991;245-250.
11. Karolczak M., Kuppers E., Beyer C. Developmental expression and regulation of aromatase- and 5alpha-reductase type I mRNA in the male and female mouse hypothalamus. J Neuroendocrinol. 10:1998;267-274.
12. Kellogg C.K., Frye C.A. Endogenous levels of 5 alpha-reduced progestins and androgens in fetal vs. adult rat brains. Dev Brain Res. 115:1999;17-24.
13. Khanna M., Qin K.N., Cheng K.C. Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humans. J Steroid Biochem Mol Biol. 53:1995;41-46.
14. Konakchieva R., Mitev Y., Almeida O.F.X., Patchev V.K. Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology. 67:1998;171-180.
15. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci Biobehav Rev. 25:2001;117-142.
16. Krieger N.R., Scott R.G. Nonneuronal localization for steroid converting enzyme 3 alpha-hydroxysteroid oxidoreductase in olfactory tubercle of rat brain . J Neurochem. 52:1989;1866-1870.
17. Laconi M.R., Casteller G., Gargiulo P.A., Bregonzio C., Cabrera R.J. The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats. Eur J Pharmacol. 417:2001;111-116.
18. Lauber M.E., Lichtensteiger W. Ontogeny of 5 alpha-reductase (type 1) messenger ribonucleic acid expression in rat brain early presence in germinal zones . Endocrinology. 137:1996;2718-2730.
19. Li X., Bertics P.J., Karavolas H.J. Regional distribution of cytosolic and particulate 5alpha-dihydroprogesterone 3 alpha-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Mol Biol. 60:1997;311-318.
20. Matsui D., Sakari M., Sato T., Murayama A., Takada I., Kim M., Takeyama K., Kato S. Transcriptional regulation of the mouse steroid 5α-reductase type II gene by progesterone in brain. Nucleic Acids Res. 30:2002;1387-1393.
21. Melcangi R.C., Poletti A., Cavarretta I., Celotti F., Colciago A., Magnaghi V., Motta M., Negri-Cesi P., Martini L. The 5α-reductase in the central nervous system expression and modes of control . J Steroid Biochem Mol Biol. 65:1998;295-299.
22. Mensah-Nyagan A.G., Do-Rego J.-L., Beaujean D., Luu-The V., Pelletier G., Vaudry H. Neurosteroids expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system . Pharm Rev. 51:1999;63-81.
23. Ojeda S.R., Urbanski H.F. Puberty in the rat. Knobil E., Neill J.D. Physiology of reproduction. Vol. 2:1994;363-409 Raven Press, New York.
24. Patchev V.K., Almeida O.F.X. Gender specificity in the neural regulation of the response to stress new leads from classical paradigms . Mol Neurobiol. 16:1998;63-77.
25. Patchev V.K., Montkowski A., Rouskova D., Koranyi L., Holsboer F., Almeida O.F.X. Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J Clin Invest. 99:1997;962-966.
26. Patchev V.K., Hassan A.H.S., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology. 15:1996;533-540.
27. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
28. Paxinos G., Watson G. The rat brain in stereotaxic coordinates. 1986;Academic Press, Sydney.
29. Penning T.M., Pawlowski J.E., Schlegel B.P., Jez J.M., Lin H.-K., Hoog S.S., Bennett M.J., Lewis M. Mammalian 3α-hydroxysteroid dehydrogenases. Steroids. 61:1996;508-523.
30. Purdy R.H., Morrow A.L., Moore Jr A.L., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA. 88:1991;4553-4557.
31. Rhodes M.E., Frye C.A. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cogn Affect Behav Neurosci. 1:2001;287-296.
32. Rosenfeld P., van Eekelen J.A.M., Levine S., de Kloet E.R. Ontogeny of corticosteroid receptors in the brain. Cell Mol Neurobiol. 13:1993;295-319.
33. Rupprecht R. The neuropsychopharmacological potential of neuroactive steroids. J Psychiat Res. 31:1997;297-314.
34. Sapolsky R.M., Meaney M.J. Maturation of the adrenocortical stress response neuroendocrine response mechanisms and the stress hyporesponsive period . Brain Res Rev. 11:1986;65-76.
35. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur J Endocrinol. 145:2001;669-679.
36. Stoffel-Wagner B., Beyenburg S., Watzka M., Blümcke I., Bauer J., Schramm J., Bidlingmaier F., Elger C.E. Expression of 5α-reductase and 3α-hydroxysteroid oxidoreductase in the hippocampus of patients with chronic temporal lobe epilepsy. Epilepsia. 41:2000;140-147.
37. Wihlback A.C., Sundström-Poromaa I., Nyberg S., Backström T. Sensitivity to a neurosteroid is increasing during addition of progestagen to menopausal hormone replacement therapy. Neuroendocrinology. 73:2001;397-407.
38. Whitfield Jr H.J., Brady L.S., Smith M.A., Mamalaki E., Fox R., Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain a detailed protocol . Cell Mol Neurobiol. 10:1990;145-157.